Androgens and penile erection: evidence for a direct relationship between free testosterone and cavernous vasodilation in men with erectile dysfunction
- 1 October 2000
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 53 (4) , 517-522
- https://doi.org/10.1046/j.1365-2265.2000.01118.x
Abstract
Androgens are essential in the maintenance of nitric oxide-mediated erectile activity in the rat. The objective of the present study was to investigate the role of androgens in regulating trabecular smooth muscle relaxation in the corpus cavernosum in response to vasoactive challenge in men with erectile dysfunction (ED). Retrospective, double-blind correlation analyses. Fifty-two impotent patients without confounding risk factors for ED were obtained from a total of 250 undergoing diagnostic evaluation. All patients had dynamic colour duplex ultrasound (D-CDU) and hormonal evaluation for LH, total and free testosterone, SHBG and oestradiol. Based upon D-CDU results patients were diagnosed as having arteriogenic (AR, n = 18; mean age 51) or corporeal venocclusive (CVO, n = 13; mean age 49) ED; in other patients (n = 21, mean age 43) a diagnosis of psychogenic (P)-ED was made by comprehensive psychogenic testing and confirmed by normal D-CDU results. AR and CVO patients had altered compliance of cavernous arteries recorded by D-CDU [20–25% lower resistive index (RI) than patients with psychogenic ED], and lower free testosterone (FT) levels than psychogenic patients [42.3 ± 3.5 SE and 49.3 ± 5.2 vs. 75.2 ± 7.6 pmol/l, respectively; P < 0.01]. More important, in all patients there was a strong direct correlation between resistive index values and FT levels (r = 0.47, P = 0.002); the relationship was maintained also when adjusted for age, SHBG and oestradiol (r = 0.37, P = 0.02). These results indicate that in men with erectile dysfuntion low free testosterone may correlate independently of age with the impaired relaxation of cavernous endothelial and corporeal smooth muscle cells to a vasoactive challenge. These findings give clinical support to the experimental knowledge of the importance of androgens in regulating smooth muscle function in the penis.Keywords
This publication has 40 references indexed in Scilit:
- Leptin and Androgens in Male Obesity: Evidence for Leptin Contribution to Reduced Androgen LevelsJournal of Clinical Endocrinology & Metabolism, 1999
- THE EFFECTS OF CASTRATION ON RELAXATION OF RAT CORPUS CAVERNOSUM SMOOTH MUSCLE IN VITROJournal of Urology, 1999
- THE EFFECTS OF CASTRATION ON RELAXATION OF RAT CORPUS CAVERNOSUM SMOOTH MUSCLE IN VITROJournal of Urology, 1999
- EX VIVO EXPRESSION OF NITRIC OXIDE SYNTHASE ISOFORMS (eNOS/iNOS) AND CALMODULIN IN HUMAN PENILE CAVERNOSAL CELLSJournal of Urology, 1998
- EX VIVO EXPRESSION OF NITRIC OXIDE SYNTHASE ISOFORMS (eNOS/iNOS) AND CALMODULIN IN HUMAN PENILE CAVERNOSAL CELLSJournal of Urology, 1998
- RESTORATION OF SEXUAL BEHAVIOR AND DOPAMINERGIC NEUROTRANSMISSION BY LONG TERM EXOGENOUS TESTOSTERONE REPLACEMENT IN AGED MALE RATSJournal of Urology, 1998
- The Effect of Testosterone on Androgen Receptors and Human Penile GrowthJournal of Urology, 1997
- The effects of testosterone on the cavernous tissue and erectile functionWorld Journal of Urology, 1997
- Dihydrotestosterone is the active androgen in the maintenance of nitric oxide-mediated penile erection in the ratEndocrinology, 1995
- Endorphins in male impotence: Evidence for naltrexone stimulation of erectile activity in patient therapyPsychoneuroendocrinology, 1989